Chemoinformaics analysis of 12,13-EPOXYOLEIC-ACID
| Molecular Weight | 295.443 | nRot | 14 |
| Heavy Atom Molecular Weight | 264.195 | nRig | 5 |
| Exact Molecular Weight | 295.227 | nRing | 1 |
| Solubility: LogS | -4.406 | nHRing | 1 |
| Solubility: LogP | 5.775 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 31 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 53.1366 |
| nHD | 1 | BPOL | 33.7034 |
| QED | 0.366 |
| Synth | 3.531 |
| Natural Product Likeliness | 1.687 |
| NR-PPAR-gamma | 0.977 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.02 |
| CACO-2 | -4.788 |
| MDCK | 0.0000332 |
| BBB | 0.182 |
| PPB | 0.980038 |
| VDSS | 0.649 |
| FU | 0.0159706 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.358 |
| CYP2c19-inh | 0.046 |
| CYP2c19-sub | 0.385 |
| CYP2c9-inh | 0.197 |
| CYP2c9-sub | 0.98 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.151 |
| CYP3a4-inh | 0.037 |
| CYP3a4-sub | 0.03 |
| CL | 3.218 |
| T12 | 0.607 |
| hERG | 0.024 |
| Ames | 0.027 |
| ROA | 0.078 |
| SkinSen | 0.901 |
| Carcinogencity | 0.269 |
| EI | 0.758 |
| Respiratory | 0.911 |
| NR-Aromatase | 0.651 |
| Antiviral | Yes |
| Prediction | 0.588371 |